690 — Uni-Bio Science Cashflow Statement
0.000.00%
Last trade - 00:00- HK$507.55m
- HK$436.49m
- HK$586.21m
Annual cashflow statement for Uni-Bio Science, fiscal year end - December 31st, HKD millions except per share, conversion factor applied.
2021 December 31st | 2022 December 31st | 2023 December 31st | R2024 December 31st | 2025 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | ARS | ARS | ARS | ARS | ARS |
| Standards: | HKAS | HKAS | HKAS | HKAS | HKAS |
| Status: | Final | Final | Final | Final | Final |
| Net Income/Starting Line | -20 | 43.3 | 75.9 | 91.2 | 102 |
| Depreciation | |||||
| Amortisation | |||||
| Non-Cash Items | 18.6 | 2.75 | 5.92 | 14.1 | 1.77 |
| Unusual Items | |||||
| Equity in Net Earnings/Losses | |||||
| Other Non-Cash Items | |||||
| Changes in Working Capital | -7.42 | -14.9 | 0.145 | -59.9 | -36 |
| Change in Accounts Receivable | |||||
| Change in Inventories | |||||
| Change in Payable / Accrued Expenses | |||||
| Change in Other Liabilities | |||||
| Other Operating Cash Flow | |||||
| Cash from Operating Activities | 12 | 48.7 | 98.8 | 66.7 | 88.8 |
| Capital Expenditures | -8.43 | -28.4 | -59.7 | -38 | -52.2 |
| Purchase of Fixed Assets | |||||
| Purchase / Acquisition of Intangibles | |||||
| Other Investing Cash Flow Items | 50.6 | 1.4 | -16.4 | -130 | 121 |
| Sale of Fixed Assets | |||||
| Sale/Maturity of Investment | |||||
| Purchase of Investments | |||||
| Other Investing Cash Flow | |||||
| Cash from Investing Activities | 42.1 | -27 | -76.1 | -168 | 68.3 |
| Financing Cash Flow Items | 7.17 | -5.22 | 2.83 | -13.7 | -0.367 |
| Other Financing Cash Flow | |||||
| Total Cash Dividends Paid | |||||
| Net Issuance / Retirement of Stock | |||||
| Net Issuance / Retirement of Debt | |||||
| Cash from Financing Activities | 0.478 | 2.58 | 24.5 | 16.8 | -34.2 |
| Foreign Exchange Effects | |||||
| Beginning Cash Balance | |||||
| Ending Cash Balance | |||||
| Net Change in Cash | 58.6 | 14.6 | 31 | -75 | 115 |